Objective: To investigate the levels and clinical value of tissue polypeptide specific antigen (TPS) in serum of patients with non-small cell lung cancer (NSCLC).
Aim: To investigate the expression of phosphorylated AKT (p-AKT) and proliferating cell nuclear antigen (PCNA) in human non-small cell lung cancer (NSCLC) tissue and their correlations.